Bayer AG (BAYN.DAX30)

Cours de clôture: 22.99 (+0.51), 25. avr 2025
Négatif

Moyen risk

Automatic technical analysis. Long terme , 25. avr 2025

Bayer AG est dans un canal baissier et un déclin poursuivant le canal est indiqué. En cas de rebondissements il y a de la résistance vers le plafond du canal. La valeur a atteint l'objectif à 21.45 après le franchissement d'une formation rectangulaire. Le cours a rebondi depuis, mais la formation indique une poursuite de la baisse. L'action s'approche de la résistance à environ 25.00 Euro, ce qui peut indiquer qu'une correction est possible. La balance des volumes est négative et affaiblit la valeur sur le court terme. L'action est généralement considéré comme negatif technique pour long terme.

Recommendation one to six quarters: Négatif (Score: -93)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-1.55%86.95+2.27%
5 jours56.365.43%70.77+9.71%
22 jours-58.7315.44%97.74-4.53%
66 jours-26.7930.42%93.00+8.04%

More analyses of Bayer AG

chart Bayer AG (BAYN) Chandeliers 22 Days
Candlesticks
chart Bayer AG (BAYN) Court terme
Court terme: Positif
chart Bayer AG (BAYN) Moyen terme
Moyen terme: Négatif
chart Bayer AG (BAYN) Long terme
Long terme : Négatif
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.